Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
Although vitamin B12 is water-soluble and excess amounts are typically excreted in the urine, the body still stores significant quantities (primarily in the liver) with its levels continuously regulated
As an investigational peptide, any legitimate clinical use involves a licensed provider, a prescription, and compounding through a licensed pharmacy
A typical protocol might look like this: Your provider will recommend a schedule based on your labs and goals
Why the Provider Matters More Than the Peptide The reason this guide keeps returning to the provider is that BPC-157 is one of those treatments where the same molecule produces completely different outcomes depending on who is behind it
Excited to see our work from the lab on subcutaneous delivery of high-concentration biologics continue on the path toward clinical translation
